
“The quality and coverage of B2B contact database are very impressive...”
Mark J.
`
+10
Heart disease is a global pandemic affecting 26 million worldwide and increasing in prevalence. More effective front-line tools are needed to identify patients earlier while lowering costs for health systems. Current conventional ECG/EKG testing, the key front-line tool, has significant limitations for detecting 2 out of 3 categories of heart disease, ischemia (CAD) and structural heart disease. HeartSciences sits at the forefront of innovation and technological development focused on advancing the field of electrocardiology to provide early heart disease detection. WHO IS HEARTSCIENCES: HeartSciences seeks to bridge todays diagnostic gap in cardiac care by providing effective front-line solutions that assist...
Medical devices,heart disease screening,electrophysiology,diastolic dysfunction,ejection fraction,ecg,12-lead ecg,myovista informatics,continuous wavelet transform,wavelet signal processing,cardiac dysfunction,wavelet ecg,wavecg,repolarization abnormalities,and relaxation abnormalities
Heartsciences (nasdaq:hscs) operates in the Medical equipment manufacturing industry.
Heartsciences (nasdaq:hscs)'s revenue is < 1m
Heartsciences (nasdaq:hscs) has 11 - 50 employees.
Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.
Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.
Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.